Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program

N3C and RECOVER Consortiums

Research output: Contribution to journalArticlepeer-review

Abstract

Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include increased incidence of diabetes. Here we describe the temporal relationship between new type 2 diabetes and SARS-CoV-2 infection in a nationwide database. We found that while the proportion of newly diagnosed type 2 diabetes increased during the acute period of SARS-CoV-2 infection, the mean proportion of new diabetes cases in the 6 months post-infection was about 83% lower than the 6 months preinfection. These results underscore the need for further investigation to understand the timing of new diabetes after COVID-19, etiology, screening, and treatment strategies.

Original languageEnglish (US)
Article numbere90
JournalJournal of Clinical and Translational Science
Volume7
Issue number1
DOIs
StatePublished - Mar 8 2023
Externally publishedYes

Keywords

  • COVID-19
  • PASC
  • epidemiology
  • new diabetes
  • type 2 diabetes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program'. Together they form a unique fingerprint.

Cite this